![Stephen Aselage](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Aselage
Presidente presso
Acuitas Therapeutics, Inc.
Profilo
Stephen J.
Aselage currently works at Acuitas Therapeutics, Inc., as Chairman and Patara Pharma LLC, as Director.
Mr. Aselage also formerly worked at Retrophin LLC, as Chief Executive Officer & Director from 2012 to 2013, Kyalin Biosciences, Inc., as Chief Executive Officer, Acer Therapeutics, Inc., as Chairman, Desert Gateway, Inc., as Chairman from 2012 to 2013, Acer Therapeutics, Inc., as Chairman from 2017 to 2023, Advanced Tissue Sciences, Inc., as Director-Sales & Marketing from 1996 to 1999, APT Pharmaceuticals, Inc., as Director, BioCryst Pharmaceuticals, Inc., as Independent Director from 2019 to 2025, Opexa Therapeutics, Inc., as Director, Travere Therapeutics, Inc., as Director from 2019 to 2022, National Pku Alliance, as Director, Genentech, Inc., as Sales Manager from 1986 to 1993, SangStat Medical Corp., as Senior VP-North American Sales & Marketing in 2004, CTI BioPharma Corp., as Executive VP-Global Commercial Operations in 2005, BioMarin Pharmaceutical, Inc., as Chief Business Officer & Executive Vice President from 2009 to 2012, Genzyme Corp., as Senior VP-North American Sales & Marketing in 2004, and Rorer Pharmaceuticals, Inc., as Sales Manager.
Mr. Aselage received his undergraduate degree in 1973 from the University of Notre Dame.
Posizioni attive di Stephen Aselage
| Società | Posizione | Inizio |
|---|---|---|
Patara Pharma LLC
 Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Provides biotechnology solutions | Direttore/Membro del Consiglio | - |
Acuitas Therapeutics, Inc.
 Acuitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops lipid nanoparticle delivery systems for nucleic acid therapeutics | Presidente | - |
Precedenti posizioni note di Stephen Aselage
| Società | Posizione | Fine |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 12/06/2025 |
| ACER THERAPEUTICS INC. | Presidente | 17/11/2023 |
| TRAVERE THERAPEUTICS, INC. | Amministratore Delegato | 04/01/2019 |
Retrophin LLC
 Retrophin LLC BiotechnologyHealth Technology Provides biotechnology services | Presidente | 21/02/2013 |
Desert Gateway, Inc.
 Desert Gateway, Inc. Financial ConglomeratesFinance Operates as a capital pool company | Presidente | 21/02/2013 |
Formazione di Stephen Aselage
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
70
Relazioni di 1° grado
20
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 20 |
|---|---|
Advanced Tissue Sciences, Inc.
 Advanced Tissue Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human-based tissue products for therapeutic applications | Commercial Services |
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
SangStat Medical Corp.
 SangStat Medical Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic and monitoring products to improve the outcome of organ transplantation | Health Technology |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
APT Pharmaceuticals, Inc.
 APT Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug development company | Health Technology |
Patara Pharma LLC
Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Provides biotechnology solutions | Health Technology |
Acer Therapeutics, Inc. /Old/
 Acer Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of orphan diseases. | Health Technology |
Desert Gateway, Inc.
Desert Gateway, Inc. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
Rorer Pharmaceuticals, Inc. | |
Retrophin LLC
Retrophin LLC BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Acuitas Therapeutics, Inc.
Acuitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops lipid nanoparticle delivery systems for nucleic acid therapeutics | Commercial Services |
Kyalin Biosciences, Inc.
 Kyalin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
National Pku Alliance
 National Pku Alliance Miscellaneous Commercial ServicesCommercial Services The National PKU Alliance (NPKUA) is an independent nonprofit organization dedicated to supporting individuals and families affected by phenylketonuria (PKU), a rare inherited metabolic disorder. The private company is based in Eau Claire, WI. The organization’s mission includes community engagement, education, advocacy, and advancing research toward improved treatments and a cure for PKU. NPKUA operates a network of regional affiliates to provide local support and resources, offers patient registries, no-cost genetic testing for eligible individuals, treatment information, and clinical trial recruitment. It funds PKU research through a grant program and supports early-stage biotech companies developing therapies. NPKUA maintains a scientific advisory board, hosts annual scientific conferences, and provides community programs such as peer support group calls, a mentor program, PKU awareness events, and practical resources like support kits and dietary tools. The company was founded by Dick Michaux. | Commercial Services |
